Predict your next investment

Corporation
HEALTHCARE | Pharmaceuticals / Drugs
meruslabs.com

See what CB Insights has to offer

Stage

Divestiture

Investors Count

1

Deal Terms

1

Portfolio Exits

1

Merus Labs Funding, Merus Labs Valuation & Merus Labs Revenue

2 Fundings

Merus Labs's latest funding round was a Acquired for on July 17, 2017.

Merus Labs's latest post-money valuation is from July 2017.

Sign up for a free 30-day trial to see Merus Labs's valuations in July 2017 and more.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

7/17/2017

Acquired

$99M

$0.00B

((9.99x))

FY 1234

3

12/22/2011

IPO

$99M

$0.00B

((9.99x))

FY 1234

10

Date

7/17/2017

12/22/2011

Round

Acquired

IPO

Amount

$99M

Investors

Valuation

$99M

Revenue

$0.00B

((9.99x))

FY 1234

$0.00B

((9.99x))

FY 1234

Sources

3

10

Merus Labs Deal Terms

1 Deal Term

Merus Labs's deal structure is available for 1 funding round, including their Acquired from July 17, 2017.

Round

Acquired

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Round

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Acquired

Merus Labs Investors

1 Investors

Merus Labs has 1 investors. Norgine invested in Merus Labs's Acquired funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

7/17/2017

7/17/2017

1
Acquired

Corporation

Netherlands

First funding

7/17/2017

Last Funding

7/17/2017

Investor

Rounds

1
Acquired

Board Seats

Type

Corporation

Location

Netherlands

Merus Labs Acquisitions

1 Acquisition

Merus Labs acquired 1 company. Their latest acquisition was UCB - Elantan, Isoket and Deponit on February 01, 2016.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

2/1/2016

Acquired Unit

1

Date

2/1/2016

Investment Stage

Companies

Valuation

Total Funding

Note

Acquired Unit

Sources

1

Merus Labs Portfolio Exits

1 Portfolio Exit

Merus Labs has 1 portfolio exit. Their latest portfolio exit was Merus Labs - Canadian Assets on October 01, 2018.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

10/1/2018

Divestiture

3

Date

10/1/2018

Exit

Divestiture

Companies

Valuation

Acquirer

Sources

3

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.